The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Milestone Pharmaceuticals Inc’s stock clocked out at $2.15, up 3.37% from its previous closing price of $2.08. In other words, the price has increased by $3.37 from its previous closing price. On the day, 5.81 million shares were traded. MIST stock price reached its highest trading level at $2.1989 during the session, while it also had its lowest trading level at $2.08.
Ratios:
To gain a deeper understanding of MIST’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 8.24 and its Current Ratio is at 8.24. In the meantime, Its Debt-to-Equity ratio is 2.79 whereas as Long-Term Debt/Eq ratio is at 2.77.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MIST now has a Market Capitalization of 183114096 and an Enterprise Value of 193024880.
Stock Price History:
The Beta on a monthly basis for MIST is 0.46, which has changed by 0.16216218 over the last 52 weeks, in comparison to a change of 0.14402747 over the same period for the S&P500. Over the past 52 weeks, MIST has reached a high of $3.06, while it has fallen to a 52-week low of $0.63. The 50-Day Moving Average of the stock is -1.39%, while the 200-Day Moving Average is calculated to be 22.51%.
Shares Statistics:
It appears that MIST traded 4.20M shares on average per day over the past three months and 15733200 shares per day over the past ten days. A total of 85.17M shares are outstanding, with a floating share count of 81.04M. Insiders hold about 4.85% of the company’s shares, while institutions hold 40.88% stake in the company. Shares short for MIST as of 1764288000 were 7389406 with a Short Ratio of 1.76, compared to 1761868800 on 4556371. Therefore, it implies a Short% of Shares Outstanding of 7389406 and a Short% of Float of 8.68.
Earnings Estimates
As of right now, 3.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.17, with high estimates of $0.55 and low estimates of -$0.22.
Analysts are recommending an EPS of between -$0.58 and -$0.81 for the fiscal current year, implying an average EPS of -$0.71. EPS for the following year is -$0.6, with 3.0 analysts recommending between -$0.11 and -$0.98.
